Vitamin E therapy results in a reduction in HDL function in individuals with Diabetes and the Haptoglobin 2-1 genotype

OBJECTIVE: Vitamin E provides cardiovascular protection to individuals with Diabetes and the haptoglobin 2-2 genotype but appears to increase cardiovascular risk in individuals with Diabetes and the haptoglobin 2-1 genotype. We have previously demonstrated that the haptoglobin protein is associated...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Farbstein, Dan, Blum, Shany, Pollak, Mordechai, Asaf, Roy, Lee Viener, Hilla, Lache, Orit, Asleh, Rabea, Miller-Lotan, Rachel, Barkay, Ido, Star, Michael, Schwartz, Avery, Kalet-Littman, Shiri, Ozeri, David, Vaya, Jacob, Tavori, Hagai, Vardi, Moshe, Laor, Arie, Bucher, Stephen E., Anbinder, Yefim, Moskovich, Doron, Abbas, Nur, Perry, Netta, Levy, Yishai, Levy, Andrew P.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3200506/
https://ncbi.nlm.nih.gov/pubmed/21722898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2011.06.005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares